Activated Partial Thromboplastin Time Test APTT

The protein C pathway the patient's protein C is activated by agkistrodon contortrix (Protac[TM]). Then, an aPTT or DVVR-based coagulation is started. These tests should screen the protein C pathway covering protein C defects, protein S defects and Factor V Leiden mutations.

This specialized coagulation test evaluates your blood's ability to clot by measuring how the activated partial thromboplastin time (aPTT) changes when normal plasma is added to your blood sample. It helps identify specific clotting factor deficiencies or inhibitors that may impair blood clotting. Results guide diagnosis of bleeding disorders, monitoring of blood-thinning medications, and assessment of clotting dysfunction in complex medical situations. This is an advanced test typically ordered by specialists.